Skip to content

Clinical trials

Observational Attention Deficit Disorder with Hyperactivity trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Observational Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20081
20101
20121
20181
20201
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of British Columbia4
University of Calgary2
Douglas Mental Health University Institute1
Duke University1
Health Sciences North Research Institute1
Nova Scotia Health Authority1
Takeda1
The Hospital for Sick Children1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity13
Feeding and Eating Disorders2
Adrenal Insufficiency1
Arrhythmias, Cardiac1
Bipolar Disorder1
Bronchopulmonary Dysplasia1
Bulimia1
COVID-191
Cellulitis1
Coronavirus Infections1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.